What a bust. No wonder why hgsi gave away the company for 14 bucks a share, after trading as high as 35 the previous year. Benlysta will go down as the most over hyped drug of all time. Almost 2 years on the market and barely generating 250 million a year in sales. Sales have flattened and so we could be near peak. Wow. The smelkster called this one 2 years ago....where did all my old friends go?...
Smelky: LOL---so this is where you hang out now? Bothering these people. At least you don;t have to use your 20 other IDs in here until you honk these people off enough!
Your old friend kutz is out making money elsewhere with HGSI profits made over the last 3-4 trading along the way! You still keep talking about HGSI in some prism with it all being about only Bene when HGSI was about several other drugs under GSK total control now.
A one dimensional thinker in a three dimensional world! Get over your Bene affliction and move on! It always was going to be a pay the bills drug--its the other drugs that are worth potentially more.